A three-level model for therapeutic drug monitoring of antimicrobials at the site of infection.

MLA

Brasier, Noé, et al. “A Three-Level Model for Therapeutic Drug Monitoring of Antimicrobials at the Site of Infection.” Lancet Infectious Diseases, vol. 23, no. 10, Oct. 2023, pp. e445–53. EBSCOhost, https://doi.org/10.1016/S1473-3099(23)00215-3.

APA

Brasier, N., Ates, H. C., Sempionatto, J. R., Cotta, M. O., Widmer, A. F., Eckstein, J., Goldhahn, J., Roberts, J. A., Gao, W., & Dincer, C. (2023). A three-level model for therapeutic drug monitoring of antimicrobials at the site of infection. Lancet Infectious Diseases, 23(10), e445–e453. https://doi.org/10.1016/S1473-3099(23)00215-3

Chicago

Brasier, Noé, H Ceren Ates, Juliane R Sempionatto, Menino O Cotta, Andreas F Widmer, Jens Eckstein, Jörg Goldhahn, Jason A Roberts, Wei Gao, and Can Dincer. 2023. “A Three-Level Model for Therapeutic Drug Monitoring of Antimicrobials at the Site of Infection.” Lancet Infectious Diseases 23 (10): e445–53. doi:10.1016/S1473-3099(23)00215-3.